Document is current

Article History

Received: 9 August 2024

Accepted: 28 February 2025

First Online: 29 May 2025

Declarations

:

: Drs. Bhojani-Lynch, Shah-Desai, and Bichet were clinical investigators for this study and received research grants from TEOXANE for study participation. Mr Kevin Poupard and Ms Bárbara Magalhães are employees of TEOXANE. The authors report no other conflicts of interest in this work.

: The EYELIGHT study was a multicenter prospective observational study. Written feedback from the Medicines and Healthcare Regulatory Agency (MHRA, UK) and the French Ethics Committee (CPP) confirmed that the EYELIGHT study did not require ethics approval by an NHS Research Ethics Committee (REC) as it was classified as research but considered a non-healthcare research study. The primary investigator (PI) of each participating site ensured that the study was conducted in compliance with the Declaration of Helsinki and national regulations applicable to Good Clinical Practice. Informed consent adhered to specific country regulatory requirements. Image rights were obtained via informed consent.

: All individuals depicted in published photographs provided informed consent for publication.